Showing results (1021-1030 of 1,171) with videos related to

Sort By:
Pageof 118
Science Translational Medicine|March 12, 2025
Itaconate restrains acute proinflammatory activation of microglia after traumatic brain injury in miceNing Liu, Yinghua Jiang, Yuwen Xiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 29, 2024
Targeting Deltex E3 Ubiquitin Ligase 2 Inhibits Tumor-associated Neutrophils and Sensitizes Hepatocellular Carcinoma Cells to ImmunotherapyXiaoling Wu, Jiafeng Chen, Yiran Chen, et al.
Surgical Endoscopy|September 16, 2024
Detailed analysis of learning phases and outcomes in robotic and endoscopic thyroidectomyJia-Fan Yu, Wen-Yu Huang, Jun Wang, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinomaZhenggang Ren, Guoliang Shao, Jie Shen, et al.
Cancer Research|November 4, 2024
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and AngiogenesisPeiyi Xie, Lei Guo, Qiang Yu, et al.
Molecular Oncology|December 10, 2020
Circulating tumor cell detection and single-cell analysis using an integrated workflow based on ChimeraX® -i120 Platform: A prospective studyPeng-Xiang Wang, Yun-Fan Sun, Wei-Xiang Jin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolizationXiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Journal of Hepatology|February 25, 2024
CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinomaPeiyi Xie, Mincheng Yu, Bo Zhang, et al.
Hepatology International|October 18, 2022
Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive proceduresZhenbin Ding, Hong Wu, Yongyi Zeng, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 14, 2022
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaGui-Qi Zhu, Yi Wang, Biao Wang, et al.
Pageof 118